Motorcar Parts of America, Inc. - Common Stock (MPAA)
6.0200
-0.2400 (-3.83%)
Motorcar Parts of America is a leading aftermarket automotive parts manufacturer and distributor, specializing in the production of various components such as starters, alternators, and brake products
The company focuses on providing high-quality, innovative solutions for vehicles, serving both domestic and international markets. With a commitment to sustainability and efficiency, Motorcar Parts leverages advanced technologies in its manufacturing processes to ensure reliability and performance, catering to the needs of both professional mechanics and individual consumers in the automotive repair industry.
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · January 15, 2025
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
MPAA stock results show that Motorcar Parts of America missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2025.
Via InvestorPlace · August 8, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · June 13, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
MPAA stock results show that Motorcar Parts of America missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2024.
Via InvestorPlace · June 11, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · June 11, 2024
![](https://cdn.benzinga.com/files/images/story/2024/06/11/MPAA.png?width=1200&height=800&fit=crop)
Motorcar Parts of America shares decline as fourth-quarter sales miss estimates, despite positive outlook for brake-related products.
Via Benzinga · June 11, 2024
![](https://cdn.benzinga.com/files/images/story/2024/04/18/image-119.png?width=1200&height=800&fit=crop)
Via Benzinga · April 18, 2024
![](https://cdn.benzinga.com/files/images/story/2024/03/06/fmc_corp_-_logo.jpg?width=1200&height=800&fit=crop)
Although U.S. stocks closed lower on Tuesday, there were a few notable insider trades.
Via Benzinga · March 6, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · February 12, 2024
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
Companies Reporting Before The Bell • TELUS (NYSETU) is expected to report quarterly earnings at $0.23 per share on revenue of $5.24 billion.
Via Benzinga · February 9, 2024
![](/next-assets/images/schema-image-default.png)
Via Benzinga · June 14, 2023
![](https://cdn.benzinga.com/files/images/story/2023/09/27/image22.jpeg?width=1200&height=800&fit=crop)
Although U.S. stocks closed lower on Tuesday, there were a few notable insider trades.
Via Benzinga · September 27, 2023
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · September 26, 2023
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · June 28, 2023
![](https://cdn.benzinga.com/files/images/story/2023/06/28/image19.jpg?width=1200&height=800&fit=crop)
Gainers Minerva Neurosciences, Inc. (NASDAQNERV) surged 46.2% to $8.80. Minerva Neurosciences announced $20 million in private placement priced at a premium to market.
Via Benzinga · June 28, 2023
![](https://cdn.benzinga.com/files/images/story/2023/06/13/stock_market_-_logo_copy.jpg?width=1200&height=800&fit=crop)
U.S. stocks traded higher toward the end of trading, with Nasdaq Composite gaining over 50 points on Tuesday. The Dow traded up 0.23% to 34,144.24 while the NASDAQ rose 0.42% to 13,518.40. The S&P 500, also rose, gaining, 0.41% to 4,356.54.
Via Benzinga · June 13, 2023
![](https://cdn.benzinga.com/files/images/story/2023/06/13/motorcar_parts_of_america__-_logo.jpg?width=1200&height=800&fit=crop)
Gainers First Wave BioPharma, Inc. (NASDAQFWBI) shares gained 143% to $2.77 after the company achieved its enrollment target for its adrulipase Phase 2 SPAN trial for exocrine pancreatic insufficiency in cystic fibrosis patients.
Via Benzinga · June 13, 2023
![](https://cdn.benzinga.com/files/images/story/2023/06/13/crude_oil_4-_logo.jpg?width=1200&height=800&fit=crop)
U.S. stocks traded higher midway through trading, with Dow Jones gaining over 100 points on Tuesday. The Dow traded up 0.42% to 34,210.67 while the NASDAQ rose 0.43% to 13,519.68. The S&P 500, also rose, gaining, 0.51% to 4,360.96.
Via Benzinga · June 13, 2023
![](https://cdn.benzinga.com/files/images/story/2023/06/13/stock_market_2_-_logo.jpg?width=1200&height=800&fit=crop)
U.S. stocks traded higher this morning, with Dow Jones gaining over 100 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.32% to 34,173.85 while the NASDAQ rose 0.72% to 13,559.01. The S&P 500, also rose, gaining, 0.49% to 4,360.39.
Via Benzinga · June 13, 2023